Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...
See how QIAGEN’s flexible pipetting technologies optimize PCR sample preparation, enabling consistent results and faster ...
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Laboratory Molecular Diagnostic for Infectious Disease Markets. Strategies and Trends. Forecasts by Application (Transplant, Respiratory, ...
Streamlining Respiratory Virus Testing with Molecular Diagnostics: Impact on patients and laboratory
Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...
"Key players in the molecular infectious disease testing market include Danaher (US), F. Hoffmann- La Roche Ltd (Switzerland), bioMérieux (France), Hologic, Inc. (US ...
SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
New York, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The global molecular diagnostics market in infectious disease testing market is projected to evolve at a CAGR of 4.4% from 2022 to 2032. The global market ...
Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback